Pooled safety summary for patients treated with the CD22-directed cytotoxi n moxetumomab pasudotox-tdfk. Kreitman, R. J., Coutre, S., Elesinmogun, C., Kuptsova-Clarkson, N., Li, X., Pastan, I., Gladstone, D. AMER SOC CLINICAL ONCOLOGY. 2019

View details for Web of Science ID 000487345806217